Pericarditis
28
6
9
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.6%
1 terminated out of 28 trials
88.9%
+2.3% vs benchmark
21%
6 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (28)
Effects of Pulmonary Rehabilitation Versus Standard Care in Patients With Pericarditis
Transition to KPL-387 Monotherapy Dosing & Administration Study
Phase 2/3 Study of KPL-387 in Recurrent Pericarditis
EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases
Pericardial Imaging Study
CACP: Study on Camptodactyly - Arthropathy - Coxa Vara - Pericarditis (CACP) Syndrome
COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry
RUDRA Registry (Real-World Clinical Registry for Patients With Recurrent Pericarditis)
COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG Wearable
Post-Ablation Pericarditis Reduction Study (PAPERS)
Inflammatory Cardiomyopathy Bern Registry
Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR Levels
Inflammation in Acute Cardiovascular Diseases - the CArdiovascular Inflammation Registry (CAIR)
ACAM2000® Myopericarditis Registry
MYocarditis and/or Pericarditis Following mRNA COVID-19 VACCination National Surveillance Study
JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors
Therapeutic Approach in Colchicine-resistant Recurrent pEricarditis in Children
Post-Ablation Pericarditis Reduction Study
Study to Evaluate the Efficacy and Safety of RPH-104 Treatment in Patients With Idiopathic Recurrent Pericarditis
A Survey of Hospitalizations in Cardiology Units in Sub-Saharan Africa